awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36752284-EA7873F6-153D-44A0-BFBD-3AB39621109C
Q36752284-EA7873F6-153D-44A0-BFBD-3AB39621109C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36752284-EA7873F6-153D-44A0-BFBD-3AB39621109C
Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study).
P2860
Q36752284-EA7873F6-153D-44A0-BFBD-3AB39621109C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36752284-EA7873F6-153D-44A0-BFBD-3AB39621109C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f2a6409f89dd3d24708cb57ea1e3d48ca48a14ac
P2860
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.